Pay to Marwadi

Company Profile

AMI ORGANICS LTD.

NSE : AMIORGBSE : 543349ISIN CODE : INE00FF01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE1242.80-6.95 (-0.56 % )
PREV CLOSE (Rs.) 1249.75
OPEN PRICE (Rs.) 1208.05
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 615
TODAY'S LOW / HIGH (Rs.)1208.05 1255.65
52 WK LOW / HIGH (Rs.)1005.05 1387.5
NSE1244.25 -6.25 (-0.5 % )
PREV CLOSE(Rs.) 1250.50
OPEN PRICE (Rs.) 1250.95
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 1244.25 (192 )
VOLUME 20716
TODAY'S LOW / HIGH(Rs.) 1240.00 1257.00
52 WK LOW / HIGH (Rs.)1004.45 1388.95

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 7.66294
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 13.51
ROCE (%) 20.67
Incorporation Year : 2007

Management Info :

Nareshkumar Patel - Chairman Nareshkumar Patel - Managing Director

Registered Office :

Address : Plot No 440/5 & 6,Road No 82, G I D C Sachin, ,
Surat,
Gujarat-394230

Phone : 7227977744 / 7573015366

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS More
17May05-17-2024$Ami Organics informs about earnings call transcript Ami Organics informs about e
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Ami Organics has enclosed the transcript of the Earnings conference call held on May 13, 2024 post announcement of financial results for the fourth quarter and year ended on March 31, 2024. The same will also be available at the website of Company at www.amiorganics.com

The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and..
16May05-16-2024$AMI Organics informs about corporate presentation AMI Organics informs about c

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ('SEBI Listing Regulations'), read with Part A of Schedule III to the SEBI Listing Regulations, AMI Organics has informed that it enclosed a copy of the corporate presentation. The said presentation shall also be uploaded on the website of the Company www.amiorganics.com.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 30 of the Securities and Exchange Board..
02May05-02-2024$Ami Organics informs about board meeting Ami Organics informs about b
Ami Organics has informed that meeting of the Board of Directors of the Company is scheduled to be held on May 10, 2024, to consider the recommendation of final dividend for the FY 2023-24 as per the details attached.

The above information is a part of company’s filings submitted to BSE.

Ami Organics has informed that meeting of the Board of Director..
15Apr04-15-2024$ Announcement Under Regulation 30 - Ecovadis Gold Accreditation. Announcement Under Regulati
Intimation of Gold Medal accreditation by EcoVadis and press release as per details attached.
Intimation of Gold Medal accreditation by EcoVadis and press re..
13Apr04-13-2024$Ami Organics informs about raising of funds Ami Organics informs about r

Ami Organics has informed that the Board has approved the raising of funds through issuance of securities or other eligible securities of the Company by way of Qualified Institutions Placement or other permissible modes as per the details attached. 

The above information is a part of company’s filings submitted to BSE.


Ami Organics has informed that the Board has approved the raisi..
Financials More
Rs. in Millions
QTR Mar 24 ANNUAL 24
Net Profit320.8436.860000000001
Gross Profit 422.88 691.110000000001
Operating Profit 487.071214.53
Net Sales 2199.386875.83
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 26643.70 (0.58%)
M.Cap ( in Cr)
56616.00
Pfizer (BSE)
 4473.85 (1.59%)
M.Cap ( in Cr)
20466.85
Glaxosmithkline Phar (BSE)
 2355.75 (2.80%)
M.Cap ( in Cr)
39907.83
Concord Biotech (BSE)
 1494.85 (4.43%)
M.Cap ( in Cr)
15638.55
Zydus Lifesciences (BSE)
 1104.45 (5.00%)
M.Cap ( in Cr)
111133.51
Shareholding Pattern More
NON-INSTITUTION 44.31 %
PROMOTERS 39.91 %
MUTUAL FUNDS/UTI 3.92 %
FI/BANKS/INSURANCE 0.31 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes